Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Source: GlobeNewswire· Smith & Nephew UK Ltd· July 29, 2026
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Smith+Nephew’s TESSA Spatial Surgery System granted De Novo classification by the FDA; a generational leap in Sports Medicine for personalized planning ...

This story was reported by GlobeNewswire. Read the full original article:
Read on GlobeNewswire

More in Products & Launches

View all